Hype to Reality: True Potential of GenAI in Private Equity

Share:
ACG EVENT

Event Details

When:

August 29, 2024 8:30 AM - 10:30 AM CDT

Where:

Register Now

Add to Calendar

Overview

Body

Generative AI rapidly revolutionized the market, prompting companies to integrate this technology and spawning numerous startups. However, the gap between hype and reality raises questions about GenAI's true potential and ROI.  In this session, we'll explore  real-world applications of GenAI in Private Equity and beyond. Haley Altman, a former M&A attorney with extensive GenAI experience, and Anthony Bahr, Managing Director of Strategex's PE Practice, will examine GenAI's possibilities in transactions, managing risk in technology investments, evaluating AI solutions, and key ROI metrics.

Speakers

Image
Anthony Bahr

Anthony Bahr

Strategex
Managing Director

Anthony is the Managing Director of Strategex’s private equity practice. He has worked with 100+ private equity firms on countless transactions to prevent deal failure and develop actionable strategies to jumpstart value creation.

Before joining Strategex, Anthony held senior-level positions at two leading market research firms where he specialized in insight, strategy, and innovation projects for global financial services, consumer packaged goods, and pharmaceutical clients.

A veteran of the United States Air Force, Anthony holds a B.B.A. in economics and international business from Loyola University Chicago, an M.S. in public policy from the University of Oklahoma as well as an MBA from the Kellogg School of Management. In his free time, Anthony volunteers with Operation HOPE, a non-profit dedicated to improving financial literacy.

Hosted by: ACG
Chapter
Chicago
Share: